The ELISA results for the expression levels of the Bax (pro-apoptotic marker) and Bcl2 (anti-apoptotic marker) showed that in the psoriasis sample, the Bax level increased to 2.9, which is more than the normal range that is 1, but after the treatments were applied, the level of Bax decreased. The gene discussed is BCL2; the disease is psoriasis.